Monday, June 8, 2026 Sign InRegister FREE My Account Help
Opinion

Opinion: Prasad’s FDA exit good for rare diseases but new CBER head must repair eroded trust – BioSpace

Opinion: Prasad’s FDA exit good for rare diseases but new CBER head must repair eroded trust  BioSpace

FlameNet Weekly: the best of the forum, freshest listings, top Q&A — delivered every Sunday.
13 members · 0 new today · 0 online now · 618 posts in last 24h